The new study indicates the third pfizer dose that can help reduce 84% of the risk of positive with the Delta transformation after about 20 days of injections, compared to two standard nose injections.

Analysis based on Maccabi Health Care Data in Israel, the country started implementing an enhanced dose of injection in mid-July, showing that the third pfizer can help reduce 48% - 68% in danger

The protection capability of the increasing dose increases over time, in which the risk of NCOV can decrease from 70% - 84% after injection from 14 -20 days.

Research on the effectiveness of the dose with the Delta transformation, announced on August 31, by the Associate Professor of Epidemiology Daniel M. Weinberger at Yale Public Health School in New Haven, Connecticut, the US leading

A vaccine of Covid-19 vaccination in Tel Aviv on August 24.

New findings show that the enhanced dose can help fight the risk of degradation of protection of the Covid-19 vaccine in the short term.

Researchers said they will continue to evaluate the effectiveness of an enhancement dose for hospitalization and death, as well as further monitoring to determine the protection time of the enhanced dose.

A study within 12 days announced by the Israeli Ministry of Health on August 29, who injecting the risk of virus infection was 11 times lower and the risk was 10 times lower than those injecting two noses.

Israel, one of the leading countries in the global vaccination, has recorded the number of incomes recently, urging the government and people boosting a strengthened injection campaign.